PAD4 activation and translocation is a critical step for NET production and dysregulated PAD4 activation is known to enhance inflammatory responses in various chronic disease such as rheumatoid arthritis and diabetes mellitus 20, 47-49. Here, PADI4 is linked to rheumatoid arthritis.